AJANTPHARM3,540.00

Ajanta Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersALKEMIPCALABTORNTPHARMABBOTINDIAANTHEMGLAXOMEDANTAGLENMARKMcap ₹44,374 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt1.52.6212.0212.0
Net Debt-458.1-611.2-451.1-451.1
Total Debt/Equity0.000.000.050.05
Net Debt/Equity-0.13-0.16-0.10-0.10
Total Debt/EBITDA0.000.000.150.15
Net Debt/EBITDA-0.39-0.49-0.32-0.31
Interest Coverage (EBIT/Interest)143.7653.8175.8375.83
Total Debt/Total Capital %0.040.074.474.47
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.